Código QR (código de barras bidimensional)

Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy

Cancer stem cells (CSCs) are the main drivers of disease progression and chemotherapy resistance in breast cancer. Tumor progression and chemoresistance might then be prevented by CSC-targeted therapies. We previously demonstrated that Toll-like Receptor (TLR)2 is overexpressed in CSCs and fuels the...

Fuld beskrivelse

Na minha lista:
Principais autores: Antonino Di Lorenzo, Elisabetta Bolli, Roberto Ruiu, Giuseppe Ferrauto, Enza Di Gregorio, Lidia Avalle, Aurora Savino, Pietro Poggio, Irene Fiore Merighi, Federica Riccardo, Mara Brancaccio, Elena Quaglino, Federica Cavallo, Laura Conti
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis Group 2022-12-01
Serier:OncoImmunology
Fag:
Breast cancer
Toll-like receptor 2
HER2
HMGB1
chemoresistance
Online adgang:https://www.tandfonline.com/doi/10.1080/2162402X.2022.2086752
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker